Status:
RECRUITING
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
Eligibility Criteria
Inclusion
- 18 years of age or older
- Ability to give informed consent
- Stage I-III breast malignancy
Exclusion
- Unable to tolerate venipuncture
Key Trial Info
Start Date :
June 4 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT04022616
Start Date
June 4 2010
End Date
December 31 2025
Last Update
March 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210